Synaptic Resilience: New Alzheimer’s Drug
Summary A promising new Alzheimer’s drug, LM11A-31, targeting synaptic resilience, has shown positive results in early clinical trials. The drug was well-tolerated by patients and demonstrated potential in mitigating brain damage. Further research is crucial […]
